Proposed Decision Memo for Screening for Hepatitis B Virus (HBV) Infection (CAG-00447N)

CMS proposes that the evidence is sufficient to conclude that screening for Hepatitis B Virus (HBV), consistent with the grade A and B recommendations by the U.S. Preventive Services Task Force (USPSTF), is reasonable and necessary for the prevention or early detection of an illness or disability and is appropriate for individuals entitled to benefits under Part A or enrolled under Part B. CMS proposes to cover screening for HBV infection with the appropriate U.S. FDA approved/cleared laboratory test. A screening test would be covered for asymptomatic, nonpregnant adolescents and adults at high risk for HBV infection. A screening test at the first prenatal visit is covered for pregnant women. In addition, CMS proposes that repeated screening during the first prenatal visit would be appropriate for each pregnancy, regardless of previous hepatitis B vaccination or previous negative hepatitis B surface antigen (HBsAg) test results.

Source: https://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=283